MediciNova Inc
NASDAQ:MNOV
MediciNova Inc
Retained Earnings
MediciNova Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MediciNova Inc
NASDAQ:MNOV
|
Retained Earnings
-$415.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Abbvie Inc
NYSE:ABBV
|
Retained Earnings
-$2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Retained Earnings
$10.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
Amgen Inc
NASDAQ:AMGN
|
Retained Earnings
-$27.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-15%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Retained Earnings
$11.2B
|
CAGR 3-Years
95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Retained Earnings
$28B
|
CAGR 3-Years
33%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
See Also
What is MediciNova Inc's Retained Earnings?
Retained Earnings
-415.7m
USD
Based on the financial report for Dec 31, 2023, MediciNova Inc's Retained Earnings amounts to -415.7m USD.
What is MediciNova Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-3%
Over the last year, the Retained Earnings growth was -2%. The average annual Retained Earnings growth rates for MediciNova Inc have been -3% over the past three years , -3% over the past five years , and -3% over the past ten years .